2fse

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2fse" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fse, resolution 3.100&Aring;" /> '''Crystallographic s...)
Line 1: Line 1:
-
[[Image:2fse.gif|left|200px]]<br />
+
[[Image:2fse.gif|left|200px]]<br /><applet load="2fse" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2fse" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2fse, resolution 3.100&Aring;" />
caption="2fse, resolution 3.100&Aring;" />
'''Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen'''<br />
'''Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen'''<br />
==Overview==
==Overview==
-
The expression of HLA-DR1 (DRB1*0101) is associated with an enhanced risk, for developing rheumatoid arthritis (RA). To study its function, we have, solved the three-dimensional structure of HLA-DR1 complexed with a, candidate RA autoantigen, the human type II collagen peptide CII, (259-273). Based on these structural data, the CII peptide is anchored by, Phe263 at the P1 position and Glu266 at P4. Surprisingly, the Lys at the, P2 position appears to play a dual role by participating in peptide, binding via interactions with DRB1-His81 and Asn82, and TCR interaction, based on functional assays. The CII peptide is also anchored by the P4, Glu266 residue through an ionic interaction with DRB1-Arg71 and Glu28., Participation of DRB1-Arg71 is significant because it is part of the, shared epitope expressed by DR alleles associated with RA susceptibility., Potential anchor residues at P6 and P9 of the CII peptide are both Gly, and the lack of side chains at these positions appears to result in both a, narrower binding groove with the peptide protruding out of the groove at, this end of the DR1 molecule. From the TCR perspective, the P2-Lys264, P5-Arg267, and P8-Lys270 residues are all oriented away from the binding, groove and collectively represent a positive charged interface for, CII-specific TCR binding. Comparison of the DR1-CII structure to a, DR1-hemagglutinin peptide structure revealed that the binding of these two, peptides generates significantly different interfaces for the interaction, with their respective Ag-specific TCRs.
+
The expression of HLA-DR1 (DRB1*0101) is associated with an enhanced risk for developing rheumatoid arthritis (RA). To study its function, we have solved the three-dimensional structure of HLA-DR1 complexed with a candidate RA autoantigen, the human type II collagen peptide CII (259-273). Based on these structural data, the CII peptide is anchored by Phe263 at the P1 position and Glu266 at P4. Surprisingly, the Lys at the P2 position appears to play a dual role by participating in peptide binding via interactions with DRB1-His81 and Asn82, and TCR interaction, based on functional assays. The CII peptide is also anchored by the P4 Glu266 residue through an ionic interaction with DRB1-Arg71 and Glu28. Participation of DRB1-Arg71 is significant because it is part of the shared epitope expressed by DR alleles associated with RA susceptibility. Potential anchor residues at P6 and P9 of the CII peptide are both Gly, and the lack of side chains at these positions appears to result in both a narrower binding groove with the peptide protruding out of the groove at this end of the DR1 molecule. From the TCR perspective, the P2-Lys264, P5-Arg267, and P8-Lys270 residues are all oriented away from the binding groove and collectively represent a positive charged interface for CII-specific TCR binding. Comparison of the DR1-CII structure to a DR1-hemagglutinin peptide structure revealed that the binding of these two peptides generates significantly different interfaces for the interaction with their respective Ag-specific TCRs.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2FSE is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FSE OCA].
+
2FSE is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FSE OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Mus musculus]]
[[Category: Mus musculus]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Ivey, R.A.]]
+
[[Category: Ivey, R A.]]
-
[[Category: Kang, A.H.]]
+
[[Category: Kang, A H.]]
-
[[Category: Park, H.W.]]
+
[[Category: Park, H W.]]
-
[[Category: Rosloniec, E.F.]]
+
[[Category: Rosloniec, E F.]]
-
[[Category: Whittington, K.B.]]
+
[[Category: Whittington, K B.]]
[[Category: antigen presentation]]
[[Category: antigen presentation]]
[[Category: collagen type ii]]
[[Category: collagen type ii]]
Line 29: Line 28:
[[Category: rheumatoid arthritis]]
[[Category: rheumatoid arthritis]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:09:58 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:24:38 2008''

Revision as of 15:24, 21 February 2008


2fse, resolution 3.100Å

Drag the structure with the mouse to rotate

Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen

Contents

Overview

The expression of HLA-DR1 (DRB1*0101) is associated with an enhanced risk for developing rheumatoid arthritis (RA). To study its function, we have solved the three-dimensional structure of HLA-DR1 complexed with a candidate RA autoantigen, the human type II collagen peptide CII (259-273). Based on these structural data, the CII peptide is anchored by Phe263 at the P1 position and Glu266 at P4. Surprisingly, the Lys at the P2 position appears to play a dual role by participating in peptide binding via interactions with DRB1-His81 and Asn82, and TCR interaction, based on functional assays. The CII peptide is also anchored by the P4 Glu266 residue through an ionic interaction with DRB1-Arg71 and Glu28. Participation of DRB1-Arg71 is significant because it is part of the shared epitope expressed by DR alleles associated with RA susceptibility. Potential anchor residues at P6 and P9 of the CII peptide are both Gly, and the lack of side chains at these positions appears to result in both a narrower binding groove with the peptide protruding out of the groove at this end of the DR1 molecule. From the TCR perspective, the P2-Lys264, P5-Arg267, and P8-Lys270 residues are all oriented away from the binding groove and collectively represent a positive charged interface for CII-specific TCR binding. Comparison of the DR1-CII structure to a DR1-hemagglutinin peptide structure revealed that the binding of these two peptides generates significantly different interfaces for the interaction with their respective Ag-specific TCRs.

Disease

Known diseases associated with this structure: Achondrogenesis-hypochondrogenesis, type II OMIM:[120140], Epiphyseal dysplasia, multiple, with myopia and deafness OMIM:[120140], Kniest dysplasia OMIM:[120140], Osteoarthrosis OMIM:[120140], Platys OMIM:[120140], SED congenita OMIM:[120140], SMD OMIM:[120140], SMED Strudwick type OMIM:[120140], Spondyloperipheral dysplasia OMIM:[120140], Stickler syndrome, type I OMIM:[120140], Vitreoretinopathy with phalangeal epiphyseal dysplasia OMIM:[120140]

About this Structure

2FSE is a Protein complex structure of sequences from Homo sapiens and Mus musculus. Full crystallographic information is available from OCA.

Reference

Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen., Rosloniec EF, Ivey RA 3rd, Whittington KB, Kang AH, Park HW, J Immunol. 2006 Sep 15;177(6):3884-92. PMID:16951351

Page seeded by OCA on Thu Feb 21 17:24:38 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools